Seres Therapeutics

Seres Therapeutics is a clinical-stage biotherapeutics company with a robust development pipeline and a rigorous scientific foundation, dedicated to revolutionizing the treatment of various diseases by modulating the function of the human microbiome. The company develops novel drugs that target the underlying biology of the human microbiome to treat significant diseases. Founded by Flagship VentureLabs, Seres pioneered the first therapeutic approach to promote health transformations by enhancing the biology of the microbiome. Current candidates address infectious diseases, metabolic diseases, and inflammatory diseases.